Subscribe To
Tslq: tesla may face headwinds, but bears should seek exposure elsewhere
AXS TSLA Bear Daily ETF is an inverse exchange-traded fund providing -1x exposure to Tesla Inc. shares. The TSLQ fund's returns can be negative even i...
November 2, 2023, 2:39 pm
Canadian natural resources limited (cnq) q3 2023 earnings call transcript
Canadian Natural Resources Limited (NYSE:CNQ ) Q3 2023 Earnings Conference Call November 2, 2023 11:00 AM ET Company Participants Lance Casson – Man...
November 2, 2023, 2:34 pm
Usa compression (usac) q3 earnings lag, revenues top estimates
USA Compression (USAC) anticipates $270-$280 million in distributable cash flow, $500-$510 million in a...
November 2, 2023, 1:33 pm
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
New data on the completed dose-escalation of this Phase 1 trial highlights promising efficacy of INB-100 in pa...
November 2, 2023, 1:17 pm
Sterling shows mixed response to boe; dollar faces mounting pressure
In the wake of BoE’s decision to maintain interest rates unchanged, Sterling exhibited a mixed performance, gaining against Dollar yet faltering whe...
November 2, 2023, 12:57 pm
Boston properties (bxp) q3 ffo & revenues top, '23 view revised
Boston Properties' (BXP) Q3 results outshine estimates on better-than-anticipated revenues, aided by he...
November 2, 2023, 12:47 pm
Boe stands pat, adopts lower rate path for economic forecasts
BoE held its Bank Rate steady at 5.25%, aligning with broad market anticipations. The decision came wit...
November 2, 2023, 12:26 pm
Organon & co (ogn) q3 2023 earnings call transcript
Organon & Co (NYSE:OGN ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO M...
November 2, 2023, 12:21 pm
Assertio holdings, inc. to release third quarter 2023 financial results on november 8, 2023
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmac...
November 2, 2023, 12:06 pm
Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc
– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in com...
November 2, 2023, 11:30 am
Camping world holdings, inc. (cwh) q3 2023 earnings call transcript
Camping World Holdings, Inc. (NYSE:CWH ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Lindsey Christen - Chief Ad...
November 2, 2023, 11:10 am
R1 rcm expands collaboration with microsoft to accelerate integration of azure openai service across the r1 enterprise
R1 launches its first LLM-based application to improve physician coding quality MURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: ...
November 2, 2023, 11:05 am
Sync your mt4 trades to tradelytic's new trading journal
Remember trading journals? For years, they have been recommended to novice and more experienced investors to meticulously track the history of their t...
November 2, 2023, 10:57 am
Airbnb stock lower after gloomy outlook
Shares of Airbnb Inc ( NASDAQ: ABNB) are 0.8% lower at $118.56 at last check, after the online lodging company issued softer guidance for the fourth ...
November 2, 2023, 10:47 am
Springworks therapeutics reports third quarter 2023 financial results and recent business highlights
– PDUFA target action date for nirogacestat NDA in adults with desmoid tumors remains set for November 27, 2023 – – On track to report topline d...
November 2, 2023, 10:30 am
Novo nordisk: 80% of u.s. wegovy patients with insurance paying less than $25/month
The majority of U.S. patients with health insurance coverage taking Novo Nordisk's powerful weight-loss...
November 2, 2023, 10:03 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...
November 2, 2023, 9:17 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...
November 2, 2023, 9:15 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
November 2, 2023, 9:10 am
Ecb's knot: policy rates now are at a good 'cruising altitude'
Current level of rates can remain for some timeShould be a little patient and not raise rates too much ...
November 2, 2023, 9:08 am